2006 - Institut für Klinische Chemie - UniversitätsSpital Zürich
2006 - Institut für Klinische Chemie - UniversitätsSpital Zürich
2006 - Institut für Klinische Chemie - UniversitätsSpital Zürich
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Universität <strong>Zürich</strong> > Medizinische Fakultät > <strong>Klinische</strong> <strong>Chemie</strong>, <strong>Institut</strong> <strong>für</strong> > Prof. Dr.<br />
Arnold von Eckardstein<br />
Lipidomics in clinical diagnostics<br />
Summary / Zusammenfassung<br />
Lipids comprise a family of biomolecules that play prominent roles in many critical metabolic and<br />
biochemical processes such as energy production and storage, the formation and functioning of<br />
cellular membranes, signal transduction, and steroidgenesis. The critical point in studying the invivo<br />
metabolism and the clinical impact of the different lipids is the need of one or several<br />
analytical methods which enable the sensitive, specific determination of the different lipid classes<br />
in their unaltered state. The title which has recently been given to the theme of studying lipids in<br />
their natural environment is lipidomics. As yet only cholesterol and its distribution in different<br />
lipoproteins as well as triglycerides have been used as diagnostic and prognostic markers. We are<br />
interested in the diagnostic and prognostic value of various lipids including oxysterols, bile acids,<br />
phospholipids and sphingolipids in human disease. Liquid chromatography mass spectrometry<br />
(LC-MS/(MS)) methods will be developed and used as analytical tools for the determination of the<br />
various lipid classes in serum and lipoprotein subfractions. Healthy individuals will be analysed to<br />
establish reference values of the different markers and to unravel associations and correlations<br />
with demographic and anthropometric measures as well as clinical biochemical markers. Well<br />
defined patient cohorts will be evaluated to unravel the association of candidate lipids with<br />
diseases, for example cardiovascular or metabolic diseases.<br />
Publications / Publikationen<br />
Burkard I, Rentsch KM, von Eckardstein A (2004) Determination of 24S- and 27hydroxycholesterol<br />
in plasma by high-performance liquid chromatography-mass spectrometry. J<br />
Lipid. Res. 45, 776-781<br />
Burkard I, von Eckardstein A, Rentsch KM (2005) Differentiated quantification fo human bile<br />
acids in serum by high-performance liquid chromatography-tandem mass spectrometry J<br />
Chromatogr. B 826, 147-159<br />
Burkard I, von Eckardstein A, Waeber G, Vollenweider P, Rentsch, KM (2007) Lipoprotein<br />
distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers.<br />
Atherosclerosis, in press<br />
Keywords / Suchbegriffe<br />
tandem mass spectrometry, liquid chromatography, drug monitoring, metabolomics, lipidomics<br />
Project Leadership and Contacts / Projektleitung und Kontakte<br />
PD Dr. Katharina Rentsch (Project Leader) rentsch@uzh.ch<br />
Prof. Dr. Arnold von Eckardstein (Project Leader) arnold.voneckardstein@ikc.usz.ch<br />
Funding Source(s) / Unterstützt durch<br />
Nachwuchsförderungskredit der Universität <strong>Zürich</strong>, EU, Foundation<br />
Duration of Project / Projektdauer<br />
Project 3273<br />
Seite 1<br />
All